Advertisement

Patients at Special Risk

  • Peter I. Folb

Keywords

Breast Milk Motion Sickness Ergot Alkaloid Human Pregnancy Ciliary Musculature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. American Academy of Pediatrics, Committee on Drugs (1979) Anticonvulsants and pregnancy. Pediatrics 63:331Google Scholar
  2. American Academy of Pediatrics, Committee on Drugs (1982) Psychotropic drugs in pregnancy Pediatrics 69:241Google Scholar
  3. Folb PI (1980) Prediction of the teratogenic potential of a new medicine. In: Safety of medicines:evaluation and prediction. Springer, Berlin Heidelberg New York, p 17Google Scholar
  4. Fraser FC (1959) Causes of congenital malformations in man. J Chronic Dis 10:97PubMedCrossRefGoogle Scholar
  5. Girling DJ (1973) Tuberculosis in pregnancy. Tubercle 54:309CrossRefGoogle Scholar
  6. Girling DJ (1982) Tuberculosis in pregnancy. Drugs 23:56PubMedCrossRefGoogle Scholar
  7. Hall JG et al. (1980) Anticoagulation during pregnancy. Am J Med 68:122PubMedCrossRefGoogle Scholar
  8. Knight AH, Phind EG (1975) Epilepsy and pregnancy. Epilepsia 16:99PubMedCrossRefGoogle Scholar
  9. Levin D et al. (1978) Non-steroidal anti-inflammatory agents. J Pediatr 92:478PubMedCrossRefGoogle Scholar
  10. Manchester D et al. (1976) Non-steroidal anti-inflammatory agents. Am J Obstet Gynecol 126:467PubMedGoogle Scholar
  11. Medicines Commission, United Kingdom (1977) Safety of drug usage during pregnancy. In: Annual report of the Medicines Commission, p 70Google Scholar
  12. Montouris GD et al. (1979) The pregnant epileptic. Arch Neurol 36:601PubMedGoogle Scholar
  13. Rao JM, Arulappu R (1981) Drug use in pregnancy. Drugs 22:409PubMedCrossRefGoogle Scholar
  14. Sadusk JF, Palmisano PA (1965) Report of an ad hoc advisory committee of the United States FDA on the teratogenicity of certain antihistamines. JAMA 194:139CrossRefGoogle Scholar
  15. Snider DE et al. (1980) Tuberculosis in pregnancy. Am Rev Respir Dis 122:65PubMedGoogle Scholar
  16. Turner G, Collins E (1975) Non-steroidal anti-inflammatory agents. Lancet II:338CrossRefGoogle Scholar
  17. Willoughby CP, Truelove SC (1980) Ulcerative colitis and pregnancy. Gut 21:469PubMedCrossRefGoogle Scholar
  18. Wilson JG (1979) Handbook of teratology, vol 1. Plenum, New YorkGoogle Scholar

Further Reading

  1. Berlin CM (1980) The excretion of drugs in human milk. In: Drugs and chemical risks to the fetus and newborn. Alan R Liss, New York, p 111Google Scholar

Further Reading

  1. Caradoc-Davies TH (1981) Opiate toxicity in elderly patients. Br Med J 283:905CrossRefGoogle Scholar
  2. Crooks J et al. (1976) Pharmocokinetics in the elderly. Clin Pharmacokinetics 1:280CrossRefGoogle Scholar
  3. Dangel ME, Havener WH (1981) Drugs in the ageing eye. Geriatrics 36:133PubMedGoogle Scholar
  4. Ramsey LE, Tucker GT (1981) Drugs and the elderly. Br Med J 282:125CrossRefGoogle Scholar
  5. Williamson J (1980) Safe prescribing for the elderly. Geriatrics 35:32PubMedGoogle Scholar

Further Reading

  1. Ozorio P (1981) Danger in mixing psychotropics with driving. Publication No 71. Division of Public Information, World Health Organisation, GenevaGoogle Scholar

Further Reading

  1. Eales L (1979) Porphyria and life-threatening drugs. S Afr Med J 56:914PubMedGoogle Scholar
  2. Disler P et al. (1982) Drugs in porphyrias. S Afr Med J 61:656 PubMedGoogle Scholar
  3. Moore MR (1980) Review of drugs in acute porphyria. Int J Biochem 12:1089PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Peter I. Folb
    • 1
    • 2
  1. 1.University of Cape Town Medical SchoolSouth Africa
  2. 2.Groote Schuur HospitalCape TownSouth Africa

Personalised recommendations